Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.
2.

Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.

Trannoy E, Berger R, Holländer G, Bailleux F, Heimendinger P, Vuillier D, Creusvaux H.

Vaccine. 2000 Feb 25;18(16):1700-6.

PMID:
10689152
3.

Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.

Oxman MN.

J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S13-7. Review.

PMID:
19553630
4.

Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.

Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ.

J Infect Dis. 2003 Nov 1;188(9):1336-44. Epub 2003 Oct 17.

PMID:
14593591
5.

Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.

Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, Irwin MR, Clair J, Smith JG, Stanley H, Marchese RD, Harbecke R, Williams HM, Chan IS, Arbeit RD, Gershon AA, Schödel F, Morrison VA, Kauffman CA, Straus SE, Schmader KE, Davis LE, Levin MJ; US Department of Veterans Affairs (VA) Cooperative Studies Program Shingles Prevention Study Investigators.

J Infect Dis. 2009 Oct 1;200(7):1068-77. doi: 10.1086/605611.

6.

Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.

Berger R, Luescher D, Just M.

Postgrad Med J. 1985;61 Suppl 4:143-5.

PMID:
3014472
7.

A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.

Holcomb K, Weinberg JM.

J Drugs Dermatol. 2006 Oct;5(9):863-6. Review.

PMID:
17039651
8.
9.

Immune response of elderly individuals to a live attenuated varicella vaccine.

Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR.

J Infect Dis. 1992 Aug;166(2):253-9.

PMID:
1321859
10.

Zoster vaccine: current status and future prospects.

Oxman MN.

Clin Infect Dis. 2010 Jul 15;51(2):197-213. doi: 10.1086/653605. Review.

PMID:
20550454
11.

An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain.

Asada H, Nagayama K, Okazaki A, Mori Y, Okuno Y, Takao Y, Miyazaki Y, Onishi F, Okeda M, Yano S, Kumihashi H, Gomi Y, Maeda K, Ishikawa T, Iso H, Yamanishi K; Shozu Herpes Zoster (SHEZ) Study group.

J Dermatol Sci. 2013 Mar;69(3):243-9. doi: 10.1016/j.jdermsci.2012.10.015. Epub 2012 Nov 5.

PMID:
23183011
12.

Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.

Liesegang TJ.

Ophthalmology. 2008 Feb;115(2 Suppl):S3-12. doi: 10.1016/j.ophtha.2007.10.009. Review.

PMID:
18243930
13.

A novel vaccine (Zostavax) to prevent herpes zoster.

Holcomb K, Weinberg JM.

G Ital Dermatol Venereol. 2008 Apr;143(2):119-23. Review.

PMID:
18833038
14.

Immune senescence and vaccines to prevent herpes zoster in older persons.

Levin MJ.

Curr Opin Immunol. 2012 Aug;24(4):494-500. doi: 10.1016/j.coi.2012.06.002. Epub 2012 Aug 2. Review.

PMID:
22857823
15.

Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy.

Weinberg A, Wiznia AA, LaFleur BJ, Shah S, Levin MJ.

J Infect Dis. 2004 Jul 15;190(2):267-70. Epub 2004 Jun 9.

PMID:
15216460
16.

Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction.

Takahashi M, Kamiya H, Asano Y, Shiraki K, Baba K, Otsuka T, Hirota T, Yamanishi K.

Arch Virol Suppl. 2001;(17):161-72. Review.

PMID:
11339545
17.

Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.

Distler E, Schnürer E, Wagner E, von Auer C, Plachter B, Wehler D, Huber C, Kolbe K, Meyer RG, Herr W.

Biol Blood Marrow Transplant. 2008 Dec;14(12):1417-24. doi: 10.1016/j.bbmt.2008.09.004.

18.

Prevention of shingles by varicella zoster virus vaccination.

Holodniy M.

Expert Rev Vaccines. 2006 Aug;5(4):431-43. Review.

PMID:
16989624
19.

Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine.

Arvin AM, Moffat JF, Redman R.

Adv Virus Res. 1996;46:263-309. Review.

PMID:
8824702
20.

Herpes zoster virus vaccine.

Woolery WA.

Geriatrics. 2008 Oct;63(10):6-9. Review.

PMID:
18828650

Supplemental Content

Support Center